Bernstein analyst Lance Wilkes maintained a Hold rating on CVS Health on September 26 and set a price target of $77.00. The company’s shares clo...
Bernstein analyst Lance Wilkes maintained a Hold rating on CVS Health on September 26 and set a price target of $77.00. The company’s shares clo...